Integer Holdings Corporation (ITGR)
USD 116.76
(2.57%)
USD 116.76
(2.57%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.94 Billion USD | 5.31% |
| 2022 | 2.79 Billion USD | 8.22% |
| 2021 | 2.58 Billion USD | 8.87% |
| 2020 | 2.37 Billion USD | 0.8% |
| 2019 | 2.35 Billion USD | 1.14% |
| 2018 | 2.32 Billion USD | -18.31% |
| 2017 | 2.84 Billion USD | 0.56% |
| 2016 | 2.83 Billion USD | -5.02% |
| 2015 | 2.98 Billion USD | 211.94% |
| 2014 | 956 Million USD | 7.33% |
| 2013 | 890.7 Million USD | 0.09% |
| 2012 | 889.87 Million USD | 0.97% |
| 2011 | 881.34 Million USD | 13.43% |
| 2010 | 776.97 Million USD | -6.45% |
| 2009 | 830.54 Million USD | -2.17% |
| 2008 | 848.93 Million USD | 27.88% |
| 2007 | 663.85 Million USD | 21.18% |
| 2006 | 547.82 Million USD | 6.81% |
| 2005 | 512.91 Million USD | 6.87% |
| 2004 | 479.93 Million USD | 9.51% |
| 2003 | 438.24 Million USD | 40.35% |
| 2002 | 312.25 Million USD | 10.13% |
| 2001 | 283.52 Million USD | 56.08% |
| 2000 | 181.64 Million USD | -4.28% |
| 1999 | 189.77 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 3.12 Billion USD | 0.33% |
| 2024 Q1 | 3.11 Billion USD | 5.89% |
| 2024 Q3 | 3.16 Billion USD | 1.32% |
| 2023 Q3 | 2.83 Billion USD | -0.77% |
| 2023 Q1 | 2.87 Billion USD | 2.83% |
| 2023 FY | 2.94 Billion USD | 5.31% |
| 2023 Q2 | 2.86 Billion USD | -0.42% |
| 2023 Q4 | 2.94 Billion USD | 3.64% |
| 2022 Q4 | 2.79 Billion USD | 2.04% |
| 2022 Q1 | 2.6 Billion USD | 1.0% |
| 2022 Q2 | 2.75 Billion USD | 5.75% |
| 2022 Q3 | 2.73 Billion USD | -0.71% |
| 2022 FY | 2.79 Billion USD | 8.22% |
| 2021 Q3 | 2.34 Billion USD | -0.47% |
| 2021 Q2 | 2.35 Billion USD | 0.67% |
| 2021 FY | 2.58 Billion USD | 8.87% |
| 2021 Q1 | 2.34 Billion USD | -1.2% |
| 2021 Q4 | 2.58 Billion USD | 9.97% |
| 2020 Q4 | 2.37 Billion USD | -3.15% |
| 2020 Q1 | 2.39 Billion USD | 1.91% |
| 2020 Q2 | 2.52 Billion USD | 5.23% |
| 2020 Q3 | 2.44 Billion USD | -2.95% |
| 2020 FY | 2.37 Billion USD | 0.8% |
| 2019 FY | 2.35 Billion USD | 1.14% |
| 2019 Q4 | 2.35 Billion USD | -0.24% |
| 2019 Q1 | 2.36 Billion USD | 1.74% |
| 2019 Q3 | 2.35 Billion USD | -0.62% |
| 2019 Q2 | 2.37 Billion USD | 0.27% |
| 2018 Q3 | 2.35 Billion USD | -16.2% |
| 2018 FY | 2.32 Billion USD | -18.31% |
| 2018 Q4 | 2.32 Billion USD | -1.24% |
| 2018 Q2 | 2.81 Billion USD | -1.25% |
| 2018 Q1 | 2.84 Billion USD | -0.05% |
| 2017 Q4 | 2.84 Billion USD | -0.18% |
| 2017 Q3 | 2.85 Billion USD | 0.3% |
| 2017 Q2 | 2.84 Billion USD | 0.28% |
| 2017 FY | 2.84 Billion USD | 0.56% |
| 2017 Q1 | 2.83 Billion USD | 0.15% |
| 2016 FY | 2.83 Billion USD | -5.02% |
| 2016 Q2 | 2.9 Billion USD | -0.36% |
| 2016 Q1 | 2.91 Billion USD | -2.32% |
| 2016 Q4 | 2.83 Billion USD | -1.84% |
| 2016 Q3 | 2.88 Billion USD | -0.58% |
| 2015 Q1 | 946.72 Million USD | -0.97% |
| 2015 Q2 | 966.13 Million USD | 2.05% |
| 2015 FY | 2.98 Billion USD | 211.94% |
| 2015 Q3 | 982.5 Million USD | 1.7% |
| 2015 Q4 | 2.98 Billion USD | 203.52% |
| 2014 FY | 956 Million USD | 7.33% |
| 2014 Q3 | 931.28 Million USD | 2.14% |
| 2014 Q4 | 956 Million USD | 2.65% |
| 2014 Q1 | 890.37 Million USD | -0.04% |
| 2014 Q2 | 911.76 Million USD | 2.4% |
| 2013 Q2 | 897.28 Million USD | 1.4% |
| 2013 Q1 | 884.92 Million USD | -0.56% |
| 2013 Q3 | 884.71 Million USD | -1.4% |
| 2013 Q4 | 890.7 Million USD | 0.68% |
| 2013 FY | 890.7 Million USD | 0.09% |
| 2012 Q3 | 891.93 Million USD | 0.69% |
| 2012 Q1 | 886.99 Million USD | 0.64% |
| 2012 FY | 889.87 Million USD | 0.97% |
| 2012 Q4 | 889.87 Million USD | -0.23% |
| 2012 Q2 | 885.79 Million USD | -0.14% |
| 2011 FY | 881.34 Million USD | 13.43% |
| 2011 Q4 | 881.34 Million USD | 8.56% |
| 2011 Q3 | 811.83 Million USD | -0.99% |
| 2011 Q2 | 819.92 Million USD | 1.41% |
| 2011 Q1 | 808.54 Million USD | 4.06% |
| 2010 FY | 776.97 Million USD | -6.45% |
| 2010 Q1 | 835.26 Million USD | 0.57% |
| 2010 Q4 | 776.97 Million USD | -5.29% |
| 2010 Q3 | 820.36 Million USD | -0.33% |
| 2010 Q2 | 823.11 Million USD | -1.45% |
| 2009 FY | 830.54 Million USD | -2.17% |
| 2009 Q2 | 837.52 Million USD | -0.65% |
| 2009 Q3 | 847.36 Million USD | 1.17% |
| 2009 Q4 | 830.54 Million USD | -1.98% |
| 2009 Q1 | 842.99 Million USD | -0.7% |
| 2008 Q2 | 829.58 Million USD | 1.84% |
| 2008 Q1 | 814.58 Million USD | 22.71% |
| 2008 FY | 848.93 Million USD | 27.88% |
| 2008 Q4 | 848.93 Million USD | 1.92% |
| 2008 Q3 | 832.93 Million USD | 0.4% |
| 2007 Q1 | 632.52 Million USD | 15.46% |
| 2007 FY | 663.85 Million USD | 21.18% |
| 2007 Q4 | 663.85 Million USD | 2.94% |
| 2007 Q3 | 644.86 Million USD | 1.79% |
| 2007 Q2 | 633.49 Million USD | 0.15% |
| 2006 Q1 | 516.81 Million USD | 0.76% |
| 2006 FY | 547.82 Million USD | 6.81% |
| 2006 Q3 | 535.29 Million USD | 0.86% |
| 2006 Q4 | 547.82 Million USD | 2.34% |
| 2006 Q2 | 530.7 Million USD | 2.69% |
| 2005 FY | 512.91 Million USD | 6.87% |
| 2005 Q1 | 483.16 Million USD | 0.67% |
| 2005 Q2 | 495.05 Million USD | 2.46% |
| 2005 Q3 | 506.95 Million USD | 2.4% |
| 2005 Q4 | 512.91 Million USD | 1.18% |
| 2004 FY | 479.93 Million USD | 9.51% |
| 2004 Q4 | 479.93 Million USD | 2.65% |
| 2004 Q3 | 467.52 Million USD | 1.22% |
| 2004 Q2 | 461.87 Million USD | 2.02% |
| 2004 Q1 | 452.73 Million USD | 3.31% |
| 2003 Q1 | 311.76 Million USD | -0.16% |
| 2003 Q3 | 428.96 Million USD | 3.64% |
| 2003 Q2 | 413.9 Million USD | 32.76% |
| 2003 Q4 | 438.24 Million USD | 2.16% |
| 2003 FY | 438.24 Million USD | 40.35% |
| 2002 FY | 312.25 Million USD | 10.13% |
| 2002 Q3 | 306.69 Million USD | 7.35% |
| 2002 Q1 | 283.1 Million USD | -0.15% |
| 2002 Q2 | 285.69 Million USD | 0.91% |
| 2002 Q4 | 312.25 Million USD | 1.81% |
| 2001 FY | 283.52 Million USD | 56.08% |
| 2001 Q1 | 184.4 Million USD | 1.52% |
| 2001 Q2 | 238.42 Million USD | 29.29% |
| 2001 Q3 | 287.37 Million USD | 20.53% |
| 2001 Q4 | 283.52 Million USD | -1.34% |
| 2000 FY | 181.64 Million USD | -4.28% |
| 2000 Q4 | 181.64 Million USD | -5.83% |
| 2000 Q3 | 192.88 Million USD | 0.0% |
| 1999 FY | 189.77 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Abbott Laboratories | 73.21 Billion USD | 95.981% |
| Allurion Technologies Inc. | 71.71 Million USD | -4003.432% |
| Artivion, Inc. | 792.39 Million USD | -271.361% |
| Avanos Medical, Inc. | 1.69 Billion USD | -73.875% |
| Butterfly Network, Inc. | 304.27 Million USD | -867.106% |
| Butterfly Network, Inc. | 304.27 Million USD | -867.106% |
| Bio-Rad Laboratories, Inc. | 12.29 Billion USD | 76.074% |
| Boston Scientific Corporation | 35.13 Billion USD | 91.625% |
| CONMED Corporation | 2.3 Billion USD | -27.94% |
| Edwards Lifesciences Corporation | 9.36 Billion USD | 68.572% |
| Paragon 28, Inc. | 340.69 Million USD | -763.71% |
| Glaukos Corporation | 940.41 Million USD | -212.91% |
| Globus Medical, Inc. | 5.08 Billion USD | 42.143% |
| Inspire Medical Systems, Inc. | 676.81 Million USD | -334.782% |
| Medtronic plc | 89.98 Billion USD | 96.73% |
| Myomo, Inc. | 14.58 Million USD | -20080.635% |
| Nevro Corp. | 635.71 Million USD | -362.89% |
| Owlet, Inc. | 44.12 Million USD | -6569.204% |
| Penumbra, Inc. | 1.55 Billion USD | -89.079% |
| Vicarious Surgical Inc. | 119.86 Million USD | -2354.993% |
| Smith & Nephew plc | 9.98 Billion USD | 70.535% |
| Sonendo, Inc. | 78.16 Million USD | -3664.909% |
| STERIS plc | 11.06 Billion USD | 73.403% |
| Stryker Corporation | 39.91 Billion USD | 92.627% |
| Vapotherm, Inc. | 77.61 Million USD | -3691.248% |
| Zimmer Biomet Holdings, Inc. | 21.49 Billion USD | 86.311% |